Opportunity Pharma OpenEye

Opportunity Pharma and OpenEye, Cadence Molecular Sciences join forces

Opportunity Pharma and OpenEye, Cadence Molecular Sciences, have signed an agreement whereby Opportunity Pharma will utilise OpenEye’s software to power the development of its proprietary AI virtual expert for drug discovery investors. OpenEye, Cadence Molecular Sciences, an industry leader in computational molecular design, has pioneered physics-based approaches and the cloud-native Orion® molecular modelling software platform […]

Opportunity Pharma and OpenEye, Cadence Molecular Sciences join forces Read More »